who reports todayUS earnings, drawn as flowsMy portfolio

← Who reports today

Health Care

9.2% — Share of covered S&P 500 companies' positive net income (10-K/20-F) · 60 companies, sorted by earnings share. Our calculation from filings, not an index weight. “deep dive →” marks a full earnings card.

Companies: earnings share and revenue growth

Sector revenue growth y/y (weighted by earnings share): +11%

PharmaceuticalsJNJ · Johnson & Johnson — revenue y/y: +5.9% · quarter ended 09/27/2026; 12.7% of the sector · 1.17% of earningsJNJ+5.9%LLY · Eli Lilly and Company — revenue y/y: +39% · quarter ended 09/30/2026; 9.8% of the sector · 0.90% of earningsLLY+39%MRK · Merck & Co. — revenue y/y: +4.7% · quarter ended 09/30/2026; 8.7% of the sector · 0.79% of earningsMRK+4.7%PFE · Pfizer — revenue y/y: −0.4% · quarter ended 09/27/2026; 3.7% of the sector · 0.34% of earningsPFE−0.4%BMY · Bristol Myers Squibb — revenue y/y: +6.9% · quarter ended 09/30/2026; 3.4% of the sector · 0.31% of earningsBMY+6.9%ZTS · Zoetis — revenue y/y: −0.2% · quarter ended 06/30/2026; 1.3% of the sector · 0.12% of earningsHealth Care ProvidersUNH · UnitedHealth Group — revenue y/y: +0.4% · quarter ended 06/30/2026; 5.7% of the sector · 0.52% of earningsUNH+0.4%HCA · HCA Healthcare — revenue y/y: +3.6% · quarter ended 09/30/2026; 3.2% of the sector · 0.30% of earningsHCA+3.6%CI · The Cigna Group — revenue y/y: +5.6% · quarter ended 09/30/2026; 2.8% of the sector · 0.26% of earningsCI+5.6%ELV · Elevance Health — revenue y/y: +1.4% · quarter ended 09/30/2026; 2.7% of the sector · 0.25% of earningsELV+1.4%MCK · McKesson — revenue y/y: +7.6% · quarter ended 09/30/2026; 2.3% of the sector · 0.21% of earningsMCK+7.6%CVS · CVS Health — revenue y/y: +5.4% · quarter ended 09/30/2026; 0.8% of the sector · 0.08% of earningsCVS+5.4%CAH · Cardinal Health — revenue y/y: +5.5% · quarter ended 09/30/2026; 0.8% of the sector · 0.07% of earningsCAH+5.5%COR · Cencora — revenue y/y: +5.1% · quarter ended 06/30/2026; 0.7% of the sector · 0.07% of earningsCOR+5.1%UHS · Universal Health Services — revenue y/y: +8.3% · quarter ended 06/30/2026; 0.7% of the sector · 0.06% of earningsUHS+8.3%HUM · Humana — revenue y/y: +26% · quarter ended 09/30/2026; 0.6% of the sector · 0.05% of earningsHUM+26%DGX · Quest Diagnostics — revenue y/y: +10% · quarter ended 09/30/2026; 0.5% of the sector · 0.04% of earningsDGXLH · Labcorp — revenue y/y: +6.9% · quarter ended 09/30/2026; 0.4% of the sector · 0.04% of earningsLHDVA · DaVita — revenue y/y: +4.6% · quarter ended 09/30/2026; 0.4% of the sector · 0.03% of earningsDVAHSIC · Henry Schein — revenue y/y: +4% · quarter ended 09/26/2026; 0.2% of the sector · 0.02% of earningsMedical DevicesABT · Abbott Laboratories — revenue y/y: +14% · quarter ended 09/30/2026; 3.1% of the sector · 0.28% of earningsABT+14%MDT · Medtronic — revenue y/y: +14% · quarter ended 07/31/2026; 2.3% of the sector · 0.21% of earningsMDT+14%SYK · Stryker — revenue y/y: +7.6% · quarter ended 09/30/2026; 1.5% of the sector · 0.14% of earningsSYK+7.6%BSX · Boston Scientific — revenue y/y: +1.4% · quarter ended 09/30/2026; 1.4% of the sector · 0.13% of earningsBSX+1.4%ISRG · Intuitive Surgical — revenue y/y: +22% · quarter ended 09/30/2026; 1.4% of the sector · 0.12% of earningsISRG+22%GEHC · GE HealthCare Technologies Inc. — revenue y/y: +7.2% · quarter ended 09/30/2026; 1% of the sector · 0.09% of earningsGEHC+7.2%BDX · Becton, Dickinson and Company — revenue y/y: +5.4% · quarter ended 06/30/2026; 0.8% of the sector · 0.07% of earningsBDX+5.4%RMD · ResMed — revenue y/y: +5.9% · quarter ended 09/30/2026; 0.7% of the sector · 0.07% of earningsRMD+5.9%EW · Edwards Lifesciences — revenue y/y: +10% · quarter ended 09/30/2026; 0.5% of the sector · 0.05% of earningsEWIDXX · IDEXX Laboratories — revenue y/y: +9.9% · quarter ended 09/30/2026; 0.5% of the sector · 0.05% of earningsIDXXDXCM · DexCom, Inc. — revenue y/y: +11% · quarter ended 09/30/2026; 0.4% of the sector · 0.04% of earningsDXCMSTE · STERIS — revenue y/y: +7.3% · quarter ended 06/30/2026; 0.4% of the sector · 0.03% of earningsSTEZBH · Zimmer Biomet — revenue y/y: +4.8% · quarter ended 06/30/2026; 0.3% of the sector · 0.03% of earningsZBHWST · West Pharmaceutical Services — revenue y/y: +8.7% · quarter ended 09/30/2026; 0.2% of the sector · 0.02% of earningsALGN · Align Technology, Inc. — revenue y/y: +1.9% · quarter ended 09/30/2026; 0.2% of the sector · 0.02% of earningsCOO · Cooper — revenue y/y: +0.6% · quarter ended 07/31/2026; 0.2% of the sector · 0.02% of earningsPODD · Insulet — revenue y/y: +19% · quarter ended 09/30/2026; 0.1% of the sector · 0.01% of earningsRVTY · Revvity — revenue y/y: +1.3% · quarter ended 07/05/2026; 0.1% of the sector · 0.01% of earningsBiotechnologyGILD · Gilead Sciences — revenue y/y: +6.8% · quarter ended 09/30/2026; 4% of the sector · 0.37% of earningsGILD+6.8%AMGN · Amgen — revenue y/y: +8.5% · quarter ended 09/30/2026; 3.7% of the sector · 0.34% of earningsAMGN+8.5%REGN · Regeneron Pharmaceuticals — revenue y/y: +36% · quarter ended 09/30/2026; 2.1% of the sector · 0.20% of earningsREGN+36%ABBV · AbbVie — revenue y/y: +10% · quarter ended 09/30/2026; 2% of the sector · 0.18% of earningsABBV+10%VRTX · Vertex Pharmaceuticals — revenue y/y: +12% · quarter ended 06/30/2026; 1.9% of the sector · 0.17% of earningsVRTX+12%BIIB · Biogen — revenue y/y: +11% · quarter ended 09/30/2026; 0.6% of the sector · 0.06% of earningsINCY · Incyte Corporation — revenue y/y: +14% · quarter ended 09/30/2026; 0.6% of the sector · 0.06% of earningsLife Sci…TMO · Thermo Fisher Scientific — revenue y/y: +9.1% · quarter ended 09/26/2026; 3.2% of the sector · 0.29% of earningsTMO+9.1%DHR · Danaher — revenue y/y: +8.3% · quarter ended 09/25/2026; 1.7% of the sector · 0.16% of earningsDHR+8.3%IQV · IQVIA — revenue y/y: +8% · quarter ended 09/30/2026; 0.6% of the sector · 0.06% of earningsIQV+8%A · Agilent Technologies, Inc. — revenue y/y: +8.1% · quarter ended 07/31/2026; 0.6% of the sector · 0.06% of earningsAMTD · Mettler-Toledo International — revenue y/y: +6.3% · quarter ended 09/30/2026; 0.4% of the sector · 0.04% of earningsMTDILMN · Illumina, Inc. — revenue y/y: +4.2% · quarter ended 09/27/2026; 0.4% of the sector · 0.04% of earningsWAT · Waters — revenue y/y: +113% · quarter ended 07/04/2026; 0.3% of the sector · 0.03% of earningsSOLV · Solventum — revenue y/y: +2.2% · quarter ended 06/30/2026; 0.7% of the sector · 0.07% of earningsSOLV+2.2%VEEV · Veeva Systems — revenue y/y: +18% · quarter ended 07/31/2026; 0.4% of the sector · 0.04% of earningsJNJ · Johnson & Johnson — revenue y/y: +5.9% · quarter ended 09/27/2026; 12.7% of the sector · 1.17% of earningsJNJ+5.9%LLY · Eli Lilly and Company — revenue y/y: +39% · quarter ended 09/30/2026; 9.8% of the sector · 0.90% of earningsLLY+39%MRK · Merck & Co. — revenue y/y: +4.7% · quarter ended 09/30/2026; 8.7% of the sector · 0.79% of earningsMRK+4.7%UNH · UnitedHealth Group — revenue y/y: +0.4% · quarter ended 06/30/2026; 5.7% of the sector · 0.52% of earningsUNH+0.4%GILD · Gilead Sciences — revenue y/y: +6.8% · quarter ended 09/30/2026; 4% of the sector · 0.37% of earningsGILD+6.8%PFE · Pfizer — revenue y/y: −0.4% · quarter ended 09/27/2026; 3.7% of the sector · 0.34% of earningsPFE−0.4%AMGN · Amgen — revenue y/y: +8.5% · quarter ended 09/30/2026; 3.7% of the sector · 0.34% of earningsAMGN+8.5%BMY · Bristol Myers Squibb — revenue y/y: +6.9% · quarter ended 09/30/2026; 3.4% of the sector · 0.31% of earningsBMY+6.9%HCA · HCA Healthcare — revenue y/y: +3.6% · quarter ended 09/30/2026; 3.2% of the sector · 0.30% of earningsHCA+3.6%TMO · Thermo Fisher Scientific — revenue y/y: +9.1% · quarter ended 09/26/2026; 3.2% of the sector · 0.29% of earningsTMO+9.1%ABT · Abbott Laboratories — revenue y/y: +14% · quarter ended 09/30/2026; 3.1% of the sector · 0.28% of earningsABT+14%CI · The Cigna Group — revenue y/y: +5.6% · quarter ended 09/30/2026; 2.8% of the sector · 0.26% of earningsCI+5.6%ELV · Elevance Health — revenue y/y: +1.4% · quarter ended 09/30/2026; 2.7% of the sector · 0.25% of earningsELV+1.4%MDT · Medtronic — revenue y/y: +14% · quarter ended 07/31/2026; 2.3% of the sector · 0.21% of earningsMDT+14%MCK · McKesson — revenue y/y: +7.6% · quarter ended 09/30/2026; 2.3% of the sector · 0.21% of earningsMCKREGN · Regeneron Pharmaceuticals — revenue y/y: +36% · quarter ended 09/30/2026; 2.1% of the sector · 0.20% of earningsREGN+36%ABBV · AbbVie — revenue y/y: +10% · quarter ended 09/30/2026; 2% of the sector · 0.18% of earningsABBV+10%VRTX · Vertex Pharmaceuticals — revenue y/y: +12% · quarter ended 06/30/2026; 1.9% of the sector · 0.17% of earningsVRTX+12%DHR · Danaher — revenue y/y: +8.3% · quarter ended 09/25/2026; 1.7% of the sector · 0.16% of earningsDHRSYK · Stryker — revenue y/y: +7.6% · quarter ended 09/30/2026; 1.5% of the sector · 0.14% of earningsSYKBSX · Boston Scientific — revenue y/y: +1.4% · quarter ended 09/30/2026; 1.4% of the sector · 0.13% of earningsBSXISRG · Intuitive Surgical — revenue y/y: +22% · quarter ended 09/30/2026; 1.4% of the sector · 0.12% of earningsISRGZTS · Zoetis — revenue y/y: −0.2% · quarter ended 06/30/2026; 1.3% of the sector · 0.12% of earningsZTSGEHC · GE HealthCare Technologies Inc. — revenue y/y: +7.2% · quarter ended 09/30/2026; 1% of the sector · 0.09% of earningsCVS · CVS Health — revenue y/y: +5.4% · quarter ended 09/30/2026; 0.8% of the sector · 0.08% of earningsCAH · Cardinal Health — revenue y/y: +5.5% · quarter ended 09/30/2026; 0.8% of the sector · 0.07% of earningsBDX · Becton, Dickinson and Company — revenue y/y: +5.4% · quarter ended 06/30/2026; 0.8% of the sector · 0.07% of earningsSOLV · Solventum — revenue y/y: +2.2% · quarter ended 06/30/2026; 0.7% of the sector · 0.07% of earningsCOR · Cencora — revenue y/y: +5.1% · quarter ended 06/30/2026; 0.7% of the sector · 0.07% of earningsRMD · ResMed — revenue y/y: +5.9% · quarter ended 09/30/2026; 0.7% of the sector · 0.07% of earningsUHS · Universal Health Services — revenue y/y: +8.3% · quarter ended 06/30/2026; 0.7% of the sector · 0.06% of earningsUHSIQV · IQVIA — revenue y/y: +8% · quarter ended 09/30/2026; 0.6% of the sector · 0.06% of earningsIQVA · Agilent Technologies, Inc. — revenue y/y: +8.1% · quarter ended 07/31/2026; 0.6% of the sector · 0.06% of earningsABIIB · Biogen — revenue y/y: +11% · quarter ended 09/30/2026; 0.6% of the sector · 0.06% of earningsINCY · Incyte Corporation — revenue y/y: +14% · quarter ended 09/30/2026; 0.6% of the sector · 0.06% of earningsHUM · Humana — revenue y/y: +26% · quarter ended 09/30/2026; 0.6% of the sector · 0.05% of earningsEW · Edwards Lifesciences — revenue y/y: +10% · quarter ended 09/30/2026; 0.5% of the sector · 0.05% of earningsIDXX · IDEXX Laboratories — revenue y/y: +9.9% · quarter ended 09/30/2026; 0.5% of the sector · 0.05% of earningsDGX · Quest Diagnostics — revenue y/y: +10% · quarter ended 09/30/2026; 0.5% of the sector · 0.04% of earningsVEEV · Veeva Systems — revenue y/y: +18% · quarter ended 07/31/2026; 0.4% of the sector · 0.04% of earningsLH · Labcorp — revenue y/y: +6.9% · quarter ended 09/30/2026; 0.4% of the sector · 0.04% of earningsMTD · Mettler-Toledo International — revenue y/y: +6.3% · quarter ended 09/30/2026; 0.4% of the sector · 0.04% of earningsILMN · Illumina, Inc. — revenue y/y: +4.2% · quarter ended 09/27/2026; 0.4% of the sector · 0.04% of earningsDXCM · DexCom, Inc. — revenue y/y: +11% · quarter ended 09/30/2026; 0.4% of the sector · 0.04% of earningsSTE · STERIS — revenue y/y: +7.3% · quarter ended 06/30/2026; 0.4% of the sector · 0.03% of earningsDVA · DaVita — revenue y/y: +4.6% · quarter ended 09/30/2026; 0.4% of the sector · 0.03% of earningsZBH · Zimmer Biomet — revenue y/y: +4.8% · quarter ended 06/30/2026; 0.3% of the sector · 0.03% of earningsWAT · Waters — revenue y/y: +113% · quarter ended 07/04/2026; 0.3% of the sector · 0.03% of earningsWST · West Pharmaceutical Services — revenue y/y: +8.7% · quarter ended 09/30/2026; 0.2% of the sector · 0.02% of earningsALGN · Align Technology, Inc. — revenue y/y: +1.9% · quarter ended 09/30/2026; 0.2% of the sector · 0.02% of earningsHSIC · Henry Schein — revenue y/y: +4% · quarter ended 09/26/2026; 0.2% of the sector · 0.02% of earningsCOO · Cooper — revenue y/y: +0.6% · quarter ended 07/31/2026; 0.2% of the sector · 0.02% of earningsPODD · Insulet — revenue y/y: +19% · quarter ended 09/30/2026; 0.1% of the sector · 0.01% of earningsRVTY · Revvity — revenue y/y: +1.3% · quarter ended 07/05/2026; 0.1% of the sector · 0.01% of earnings
Color scale
Revenue growth y/y, %no data
As a list: all 60 companies
How to read the map

Rectangle size is the company’s share of S&P 500 companies’ shareholder earnings; together they make up the whole sector. On a wide screen companies are grouped by GICS industry, labelled above each group. The tiniest ones are combined into a “+N” tile.

Color is revenue growth y/y in the latest report: red — revenue fell, green — it grew (darker is stronger), light — roughly flat (±1%), hatched — no data.

Map as an image (PNG)

Share of covered S&P 500 companies' positive net income (10-K/20-F). Our calculation from company filings, not an index weight. Each company's latest full fiscal year (periods may differ), profit attributable to owners of the parent in USD: consolidated profit excluding noncontrolling interests. This is not a dividend measure. Losses and zero earnings receive a zero share. Coverage: 473 of 499 issuers; 26 without unambiguously extractable data are excluded from the denominator. The denominator sums positive earnings of covered issuers; each company is counted once regardless of its number of share classes. Checked 2026-11-16; refresh after annual filings and membership changes, check at least monthly. Membership: S&P DJI releases; GICS sectors: constituent register. Color: year-over-year revenue change in the latest quarter, from SEC XBRL and our report cards. Tap a tile to open the report; if the ticker didn’t fit on the tile or there is no report yet, we show the name and numbers.

The latest reports of 60 companies in the sector at a glance. Fastest revenue growth: Waters (+121%); slowest: Charles River Laboratories International (−2.2%). Largest net income: Eli Lilly and Company. Full comparison below.

Latest earnings: Health Care compared

Johnson & JohnsonQ3 2026$25,399+5.9%$210−95.9%Oct 13, 2026
Eli Lilly and CompanyQ3 2026$24,397+38.6%$6,451+15.5%Oct 29, 2026
Merck & Co.Q3 2026$18,085+4.7%$5,065−12.4%Oct 29, 2026
UnitedHealth GroupQ3 2026$112,694−0.4%$4,110+75.0%Oct 13, 2026
Gilead SciencesQ3 2026$8,300+6.8%$2,429−20.4%Oct 29, 2026
PfizerQ3 2026$16,583−0.4%$3,242−8.4%Nov 3, 2026
AmgenQ3 2026$10,365+8.5%$3,864+20.1%Nov 3, 2026
Bristol Myers SquibbQ3 2026$13,069+6.9%$2,162−1.8%Oct 29, 2026
HCA HealthcareQ3 2026$19,849+3.6%$1,579−3.9%Oct 27, 2026
Thermo Fisher ScientificQ3 2026$12,137+9.1%$1,721+6.5%Oct 21, 2026
Abbott LaboratoriesQ3 2026$13,013+14.5%$920−44.0%Oct 21, 2026
CignaQ3 2026$73,683+5.6%$1,442−22.8%Nov 5, 2026
Elevance HealthQ3 2026$51,429+1.4%$1,365+14.8%Oct 21, 2026
MedtronicQ1 2027 previous$9,756+13.7%$1,470+41.4%Sep 1, 2026
McKessonQ1 FY2027 previous$105,380+7.7%$1,032+24.2%Aug 5, 2026
Regeneron PharmaceuticalsQ3 2026$5,116+36.3%$1,949+33.5%Oct 30, 2026
AbbVieQ3 2026$17,404+10.3%$4,218Oct 30, 2026
Vertex PharmaceuticalsQ3 2026$3,441+11.8%$654−39.6%Nov 2, 2026
DanaherQ3 2026$6,554+8.3%$1,235+36.0%Oct 21, 2026
StrykerQ3 2026$6,520+7.6%$753−12.3%Oct 29, 2026
Boston ScientificQ3 2026$5,138+1.4%$582−22.9%Oct 28, 2026
Intuitive SurgicalQ3 2026$3,049+21.7%$523−25.8%Oct 20, 2026
ZoetisQ3 2026$2,391−1.3%$591−18.0%Nov 5, 2026
GE HealthCare TechnologiesQ3 2026$5,513+7.2%$615+37.9%Oct 28, 2026
CVS HealthQ3 2026$108,399+5.4%$2,172Nov 4, 2026
Cardinal HealthQ1 FY2027$67,513+5.5%$554+23.1%Nov 5, 2026
Becton, DickinsonQ4 FY2026 previous$5,274+5.4%$696+41.2%Nov 5, 2026
SolventumQ2 2026 previous$2,209+2.2%$92+2.2%Aug 5, 2026
CencoraQ4 FY2026 previous$88,355+5.5%$519Nov 4, 2026
ResMedQ1 FY2027$1,415+5.9%$418+20.0%Oct 29, 2026
Universal Health ServicesQ3 2026$4,733+5.3%$309−17.2%Oct 27, 2026
IQVIAQ3 2026$4,428+8.0%$350+5.7%Oct 27, 2026
Agilent TechnologiesQ3 FY2026 previous$1,878+8.1%$362+7.7%Aug 26, 2026
BiogenQ3 2026$2,804+10.6%—Oct 28, 2026
IncyteQ2 2026 previous$1,674+37.7%$586+44.6%Jul 28, 2026
HumanaQ2 2026 previous$40,867+26.2%$694+27.3%Jul 29, 2026
Edwards LifesciencesQ2 2026 previous$1,741+13.6%$242−27.4%Jul 23, 2026
IDEXX LaboratoriesQ3 2026$1,214+9.9%$317+15.5%Nov 2, 2026
Quest DiagnosticsQ3 2026$3,097+10.0%$312+27.3%Oct 22, 2026
Veeva SystemsQ2 FY2027 previous$928+17.6%$273+36.5%Aug 26, 2026
LabcorpQ3 2026$3,810+6.9%$263+0.7%Oct 28, 2026
Mettler-Toledo InternationalQ3 2026$1,094+6.3%$246+13.1%Nov 5, 2026
IlluminaQ3 2026$1,129+4.2%$220+46.7%Oct 29, 2026
DexComQ3 2026$1,345+11.2%$275−3.1%Oct 29, 2026
STERISQ2 FY2027 previous$1,589+8.8%$214+11.4%Nov 4, 2026
DaVitaQ3 2026$3,578+4.6%$223+48.3%Oct 29, 2026
Zimmer BiometQ3 2026$2,063+3.1%$192−17.0%Nov 4, 2026
WatersQ3 2026$1,767+121%$81−45.6%Nov 3, 2026
West Pharmaceutical ServicesQ3 2026$875+8.7%$214+52.9%Oct 29, 2026
Align TechnologyQ3 2026$1,015+1.9%$135+138%Oct 28, 2026
Henry ScheinQ3 2026$3,471+4.0%$119+17.8%Nov 3, 2026
CooperQ3 FY2026 previous$1,066+0.6%$433+340%Sep 9, 2026
InsuletQ3 2026$842+19.2%$141+61.1%Nov 4, 2026
RevvityQ3 2026$729+4.3%$62.3+33.5%Nov 3, 2026
Baxter InternationalQ3 2026$2,976+5.0%$294Oct 29, 2026
CenteneQ3 2026$50,647+1.9%—Oct 27, 2026
Charles River Laboratories InternationalQ3 2026$983−2.2%$333+512%Nov 4, 2026
ModernaQ2 2026 previous$145+2.1%—Jul 31, 2026
Bio-TechneQ4 FY2026 previous$321+1.3%$54.6Aug 12, 2026
ViatrisQ2 2026 previous$3,757+4.9%—Aug 6, 2026

Amounts in $ millions; changes vs the same period a year earlier. Figures come from our verified earnings breakdowns; fiscal periods differ between companies.

Shareholders’ equity in Health Care

Negative equity: HCA Healthcare (−$8.1B), AbbVie (−$4.6B), McKesson (−$4.0B), Cardinal Health (−$3.0B), DaVita (−$0.59B). Equity, assets and change since year-end →

Find companies on your own terms — revenue growth, debt, dividends without a gap, F-score:the fundamental screener· S&P 500 companies with revenue growth 10 years in a row· S&P 500 companies with no net debt

Other sectors

Information Technology 28.9% · Financials 20.6% · Communication Services 13% · Industrials 7.9% · Consumer Discretionary 7.6% · Consumer Staples 4.7% · Energy 2.8% · Utilities 2.4% · Materials 1.6% · Real Estate 1.3%

Cookies the site needs and, with your consent, Google Analytics — privacy policy